Skip Nav Destination

Issues

Select Year

Select Issue

Volume 6, Issue 4

1 July 2016

eISSN 2168-9709

In this Issue

PHYSICAL SIDE EFFECTS OF PSYCHOACTIVE MEDS
COGNITIVE SIDE EFFECTS OF NON-PSYCHOACTIVE MEDS

Physical Side Effects of Psychoactive Meds/Cognitive Side Effects of Non-Psychoactive Meds, Vol. 6, Iss. 4

PHYSICAL SIDE EFFECTS OF PSYCHOACTIVE MEDS

Evaluation of QTc prolongation and dosage effect with citalopram

Justine McClelland, PharmD, BCPP; Monica Mathys, PharmD, BCPP, CGP

Abstract

View Article

PDF

Evaluation of the use of electrocardiogram monitoring in patients on psychotropic medications that have a risk of QT prolongation

Sandra J. Girgis, PharmD; Megan E. Maroney, PharmD, BCPP; Mei T. Liu, PharmD, BCPP

Abstract

View Article

PDF

Atypical antipsychotics: A review on the prevalence, monitoring, and management of their metabolic and cardiovascular side effects

Joyce Wei Xin Chong, MPharm (Hons); Earl Hsien-Jie Tan, BSc Pharm (Hons); Chia Eng Chong, BPharm; Yiwei Ng, BSc Pharm (Hons); Ruki Wijesinghe, PharmD, BCPP

Abstract

View Article

PDF

Management of antipsychotic-induced hyperprolactinemia

Ashley Tewksbury, PharmD, BCPP; Amy Olander, BS

Abstract

View Article

PDF

Sexual dysfunction in selective serotonin reuptake inhibitors (SSRIs) and potential solutions: A narrative literature review

Elizabeth Jing, BS; Kristyn Straw-Wilson, PharmD, BCPP

Abstract

View Article

PDF

Priapism and renal colic in a patient treated with duloxetine

G. Lucy Wilkening, PharmD; Shelly A. Kucherer, MD; Antoine B. Douaihy, MD

Abstract

View Article

PDF

COGNITIVE SIDE EFFECTS OF NON-PSYCHOACTIVE MEDS

Drug-induced cognitive impairment: Effect of cardiovascular agents

Marketa Marvanova, PharmD, PhD, CGP, BCPP

Abstract

View Article

PDF

Antimicrobial-induced cognitive side effects

Amanda Warstler, PharmD, BCPS; Jennifer Bean, PharmD, BCPS, BCPP

Abstract

View Article

PDF

Cover Image

Cover Image

All Issues

Latest
Most Read

2022 MHC Awards and Recognition

Erica A. K. Davis, PharmD, BCPS, BCPP, Amy VandenBerg, PharmD, BCPP

A preliminary evaluation of N-acetylcysteine's effects on patient adherence to treatment for cocaine use disorder

Jake Schechter, DNP, PMHNP-BC, RN, Geoffrey W. Brown, PharmD, Maria Janda, PharmD

Post hoc depression analysis from a pharmacist-led diabetes trial

M. Thomas Bateman, PharmD, BCACP, Caitlin McCarthy, PharmD, BCPP, Katherine M. Prioli, MS, Mary L. Wagner, MS, PharmD

Best practices for documentation of psychotropic drug-drug interactions in an adult psychiatric clinic

Kathryn Collins, PharmD, MSPH, Julie A. Dopheide, PharmD, BCPP, FASHP, Mengxi Wang, MPH, Talene Keshishian, MD

Comparison of antipsychotic prescribing practices following failure of antipsychotic monotherapy in the acute care setting

Kaitlyn Morgan, PharmD, BCPP, Leah Rickert, PharmD, BCPP

Issues

Physical Side Effects of Psychoactive Meds/Cognitive Side Effects of Non-Psychoactive Meds, Vol. 6, Iss. 4

PHYSICAL SIDE EFFECTS OF PSYCHOACTIVE MEDS

COGNITIVE SIDE EFFECTS OF NON-PSYCHOACTIVE MEDS

Cover Image

This Feature Is Available To Subscribers Only